Do We Have Enough Evidence for Adjuvant Postoperative Chemoradiation in Esophageal Cancer?

Journal of Thoracic Disease - Hong Kong
doi 10.21037/jtd.2017.06.49
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Ketamine or Ketofol: Do We Have Enough Evidence to Know Which One to Use?

Academic Emergency Medicine
MedicineEmergency Medicine
2017English

Shifting Practice in Definitive Chemoradiation for Localized Esophageal Cancer

Current Oncology
Oncology
2017English

Do Households Have Enough Wealth for Retirement?

Finance and Economics Discussion Series
2007English

Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer

Pancreatic Disorders & Therapy
2015English

Adjuvant Chemoradiation for Resected Gastric Cancer: A 10-Year Experience

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2011English

Roma Health: Do We Know Enough?

International Journal of Public Health
EnvironmentalPublic HealthHealthOccupational Health
2019English

Obstructive Sleep Apnea and Tonsillectomy: Do We Have a New Indication for Extended Postoperative Observation?

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2004English

Comparison of Perioperative Chemotherapy and Adjuvant Chemoradiation in Resected Gastric Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Estrogen Receptor Beta in Colorectal Cancer Prevention: Do We Have Conclusive Proof?

Journal of Genetic Syndromes & Gene Therapy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy